Effects of ONO-2506PO in Patients With Alzheimer's Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
50 Years to 90 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Diagnosis of probable Alzheimer's Disease using NINCDS/ADRDA criteria
Standardized MMSE Score of 13 to 24 points (inclusive)
Modified Hachinski score equal or less than 4
Serious systemic disease that may preclude survival to study completion
Other illnesses that may include dementive features